Enavate Sciences’s CAMP4 Therapeutics Corporation Common Stock CAMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.49M Hold
3,785,802
3.11% 6
2025
Q1
$15.1M Hold
3,785,802
11.41% 4
2024
Q4
$19.8M Buy
+3,785,802
New +$19.8M 14.19% 4